av/bio-techne--big.svg

COM:BIO-TECHNE

Bio-Techne

  • Stock

Last Close

71.05

22/11 21:00

Market Cap

11.36B

Beta: -

Volume Today

589.91K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24
average inventory
36.86M
-
44.21M
19.94%
53.34M
20.64%
58.63M
9.91%
72.90M
24.35%
88.35M
21.19%
97.10M
9.91%
109.95M
13.23%
128.94M
17.27%
156.38M
21.29%
175.68M
12.34%
average payables
13.09M
-
25.17M
92.26%
37.14M
47.57%
49.87M
34.26%
59.70M
19.73%
67.40M
12.89%
67.25M
0.22%
79.61M
18.38%
104.83M
31.67%
95.50M
8.90%
57.64M
39.65%
average receivables
44.02M
-
58.95M
33.91%
81.71M
38.61%
105.11M
28.63%
118.56M
12.80%
128.88M
8.70%
130M
0.87%
133.96M
3.05%
169.97M
26.88%
206.51M
21.50%
229.93M
11.34%
book value per share
5.39
-
5.71
5.91%
5.91
3.55%
6.37
7.79%
7.20
13.00%
7.71
7.14%
9.04
17.19%
10.14
12.16%
10.84
6.96%
12.51
15.39%
13.12
4.85%
capex per share
-0.09
-
-0.13
43.22%
-0.11
15.33%
-0.10
10.46%
-0.14
37.31%
-0.17
20.41%
-0.34
101.39%
-0.29
15.59%
-0.29
0.15%
-0.24
15.00%
0.40
263.86%
capex to depreciation
-0.72
-
-0.53
25.82%
-0.40
26.10%
-0.25
36.02%
-0.32
28.44%
-0.33
0.10%
-0.63
92.39%
-0.50
19.27%
-0.44
11.99%
-0.36
19.74%
0.56
257.83%
capex to operating cash flow
-0.10
-
-0.14
41.34%
-0.12
17.77%
-0.11
9.91%
-0.12
16.12%
-0.14
13.87%
-0.25
80.21%
-0.13
50.11%
-0.14
9.75%
-0.15
8.89%
0.21
239.89%
capex to revenue
-0.04
-
-0.04
13.93%
-0.03
23.06%
-0.03
20.38%
-0.03
20.76%
-0.04
9.31%
-0.07
96.82%
-0.05
32.07%
-0.04
14.64%
-0.03
17.17%
0.05
261.24%
cash per share
2.46
-
0.75
69.64%
0.64
13.83%
1.06
64.04%
1.21
14.74%
1.10
9.39%
1.77
61.36%
1.49
15.73%
1.57
5.40%
1.30
17.45%
0.97
25.43%
days of inventory on hand
133.32
-
124.82
6.37%
128.37
2.84%
116.50
9.25%
148.26
27.27%
138.18
6.80%
147.36
6.65%
142.91
3.02%
147.55
3.25%
170.76
15.73%
169.96
0.47%
days payables outstanding
68.45
-
76.52
11.78%
98.67
28.95%
108.15
9.61%
110.04
1.74%
108.11
1.75%
90.39
16.39%
117.46
29.96%
118.88
1.21%
76.91
35.31%
35.90
53.32%
days sales outstanding
48.84
-
56.52
15.73%
68.31
20.85%
75.74
10.88%
68.29
9.84%
70.27
2.91%
60.55
13.84%
57.00
5.86%
64.23
12.69%
70.15
9.22%
76.02
8.36%
debt to assets
0.02
-
0.11
627.07%
0.12
8.51%
0.22
89.81%
0.22
2.86%
0.27
22.77%
0.21
20.24%
0.19
13.08%
0.14
23.57%
0.17
21.38%
0.12
31.57%
debt to equity
0.02
-
0.14
741.71%
0.15
11.02%
0.37
141.91%
0.32
12.40%
0.43
34.44%
0.31
27.58%
0.27
14.73%
0.19
28.40%
0.23
20.73%
0.16
30.65%
dividend yield
0.01
-
0.01
3.01%
0.01
11.97%
0.01
4.92%
0.01
19.84%
0.01
29.29%
0.00
20.77%
0.00
41.33%
0.00
29.79%
0.00
6.17%
0.00
13.91%
earnings yield
0.03
-
0.03
9.24%
0.02
15.53%
0.02
29.25%
0.02
28.26%
0.01
46.24%
0.02
87.03%
0.01
64.59%
0.02
148.66%
0.02
11.10%
0.01
33.05%
enterprise value
3.11B
-
3.71B
19.49%
4.26B
14.77%
4.64B
8.91%
5.76B
24.09%
8.31B
44.21%
10.38B
24.86%
17.67B
70.30%
13.75B
22.19%
13.10B
4.68%
11.56B
11.78%
enterprise value over ebitda
19.46
-
25.27
29.83%
28.31
12.05%
38.13
34.67%
42.31
10.98%
56.64
33.85%
65.91
16.37%
74.46
12.97%
34.57
53.57%
32.26
6.68%
31.70
1.76%
ev to operating cash flow
22.73
-
26.66
17.26%
29.63
11.17%
32.37
9.23%
33.82
4.48%
45.75
35.28%
50.56
10.50%
50.17
0.76%
42.27
15.75%
51.51
21.88%
38.67
24.94%
ev to sales
8.69
-
8.21
5.48%
8.54
4.01%
8.25
3.47%
8.96
8.65%
11.64
29.87%
14.05
20.68%
18.98
35.12%
12.44
34.47%
11.53
7.29%
9.97
13.48%
free cash flow per share
0.83
-
0.81
3.38%
0.85
6.01%
0.86
0.70%
1.00
15.99%
1.03
3.69%
1.00
2.83%
1.99
97.77%
1.79
10.03%
1.38
23.05%
1.50
8.87%
free cash flow yield
0.04
-
0.03
9.18%
0.03
7.41%
0.03
3.38%
0.03
7.87%
0.02
26.68%
0.02
23.01%
0.02
15.99%
0.02
16.87%
0.02
18.31%
0.02
24.10%
graham net net
2.38
-
-0.19
107.98%
-0.38
97.41%
-2.21
490.29%
-1.33
39.96%
-2.67
101.20%
-1.52
43.22%
-1.89
24.40%
-0.83
56.03%
-1.39
67.14%
-2.03
46.42%
graham number
9.55
-
9.66
1.13%
9.66
0.07%
8.62
10.85%
11.64
35.09%
10.50
9.75%
17.47
66.32%
14.38
17.71%
20.57
43.09%
22.60
9.89%
17.74
21.53%
income quality
1.23
-
1.29
4.94%
1.38
6.46%
1.89
36.91%
1.35
28.37%
1.89
39.98%
0.89
52.66%
2.52
181.90%
1.24
51.00%
0.89
27.91%
1.78
99.60%
intangibles to total assets
0.30
-
0.64
113.01%
0.66
2.11%
0.66
1.04%
0.66
1.16%
0.70
6.24%
0.61
11.82%
0.64
5.01%
0.59
8.51%
0.53
9.58%
0.53
1.38%
interest coverage
95.22
-
86.15
9.53%
16.54
80.80%
13.37
19.21%
5.79
56.71%
3.89
32.76%
10.72
175.53%
26.23
144.67%
-26.66
201.64%
16.08
160.33%
interest debt per share
0.09
-
0.79
803.28%
0.91
14.93%
2.39
162.81%
2.39
0.21%
3.49
45.95%
2.96
15.02%
2.80
5.38%
2.15
23.31%
2.82
31.31%
2.20
21.92%
inventory turnover
2.74
-
2.92
6.81%
2.84
2.76%
3.13
10.19%
2.46
21.43%
2.64
7.30%
2.48
6.23%
2.55
3.12%
2.47
3.14%
2.14
13.59%
2.15
0.47%
invested capital
0.02
-
0.14
741.71%
0.15
11.02%
0.37
141.91%
0.32
12.40%
0.43
34.44%
0.31
27.58%
0.27
14.73%
0.19
28.40%
0.23
20.73%
2.28B
985,591,202,095.33%
market cap
3.41B
-
3.65B
6.99%
4.19B
14.80%
4.39B
4.55%
5.54B
26.45%
7.91B
42.57%
10.09B
27.61%
17.45B
72.95%
13.59B
22.08%
12.83B
5.62%
11.29B
11.98%
net current asset value
402.19M
-
31.86M
92.08%
3.66M
88.50%
-260.57M
7,211.54%
-115.69M
55.60%
-306.21M
164.68%
-125.48M
59.02%
-181.12M
44.34%
11.76M
106.49%
-50.69M
531.00%
-126.92M
150.37%
net debt to ebitda
-1.91
-
0.42
121.87%
0.46
10.34%
2.12
359.41%
1.59
24.86%
2.76
72.91%
1.82
33.86%
0.93
48.79%
0.39
58.67%
0.68
75.12%
0.73
8.66%
net income per share
0.75
-
0.73
3.44%
0.70
3.28%
0.52
26.26%
0.84
61.48%
0.64
23.98%
1.50
136.05%
0.91
39.63%
1.73
91.42%
1.81
4.65%
1.07
41.27%
operating cash flow per share
0.93
-
0.94
1.33%
0.97
2.96%
0.96
0.61%
1.14
18.25%
1.20
5.74%
1.34
11.75%
2.27
69.19%
2.07
8.75%
1.62
21.94%
1.90
17.13%
payables turnover
5.33
-
4.77
10.54%
3.70
22.45%
3.37
8.77%
3.32
1.71%
3.38
1.78%
4.04
19.61%
3.11
23.05%
3.07
1.19%
4.75
54.58%
10.17
114.21%
receivables turnover
7.47
-
6.46
13.59%
5.34
17.26%
4.82
9.81%
5.35
10.92%
5.19
2.83%
6.03
16.06%
6.40
6.23%
5.68
11.26%
5.20
8.44%
4.80
7.72%
research and ddevelopement to revenue
0.09
-
0.09
4.44%
0.09
0.24%
0.10
4.97%
0.09
9.47%
0.09
1.58%
0.09
0.96%
0.08
14.07%
0.08
3.93%
0.08
3.24%
0.08
2.49%
return on tangible assets
0.18
-
0.28
53.94%
0.27
5.10%
0.15
45.24%
0.23
54.92%
0.17
26.48%
0.29
74.51%
0.17
40.38%
0.29
65.50%
0.23
19.85%
0.13
45.58%
revenue per share
2.42
-
3.05
25.71%
3.35
10.05%
3.77
12.46%
4.29
13.71%
4.72
10.15%
4.83
2.32%
6.01
24.26%
7.05
17.32%
7.23
2.62%
7.35
1.62%
roe
0.14
-
0.13
8.82%
0.12
6.59%
0.08
31.59%
0.12
42.90%
0.08
29.04%
0.17
101.41%
0.09
46.17%
0.16
78.97%
0.15
9.30%
0.08
43.99%
roic
0.14
-
0.11
21.48%
0.11
1.30%
0.06
39.28%
0.09
48.52%
0.06
32.12%
0.03
49.21%
0.07
107.74%
0.12
81.50%
0.10
19.22%
0.10
4.32%
sales general and administrative to revenue
0.17
-
0.26
55.57%
0.28
6.93%
0.27
3.53%
0.37
37.42%
0.33
11.36%
0.33
1.70%
0.31
4.51%
0.31
1.53%
0.31
1.12%
0.34
10.42%
shareholders equity per share
5.39
-
5.71
5.91%
5.91
3.55%
6.37
7.79%
7.20
13.00%
7.71
7.14%
9.04
17.19%
10.14
12.16%
10.84
6.96%
12.51
15.39%
13.12
4.85%
stock based compensation to revenue
0.01
-
0.01
33.76%
0.02
43.46%
0.03
37.52%
0.04
69.00%
0.05
2.94%
0.04
3.08%
0.05
20.07%
0.04
27.48%
0.03
9.55%
0.03
4.90%
tangible asset value
535.02M
-
163.46M
69.45%
137.95M
15.61%
-81.44M
159.04%
34.92M
142.88%
-146.51M
519.51%
136.34M
193.06%
112.20M
17.71%
347.39M
209.62%
559.13M
60.95%
589.11M
5.36%
tangible book value per share
3.63
-
1.10
69.62%
0.93
15.87%
-0.54
158.01%
0.23
143.33%
-0.97
516.13%
0.89
192.04%
0.72
18.87%
2.21
205.89%
3.56
60.64%
3.74
5.01%
working capital
443.02M
-
208.51M
52.93%
199.74M
4.21%
209.90M
5.09%
319.68M
52.30%
310.62M
2.83%
414.25M
33.36%
358.32M
13.50%
429.54M
19.87%
492.97M
14.77%
458.04M
7.09%

All numbers in (except ratios and percentages)